PLX
(NYSEAMERICAN)Protalix BioTherapeutics, Inc.
---- (--)
Loading... - Market loading
Protalix BioTherapeutics (PLX) Stock Price & Financial Analysis
Protalix BioTherapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$2.95 - $3.02
52-Week High$3.10
52-Week Low$1.32
Open$2.98
Volume1.01M
Average Volume (3M)1.01M
Market Cap240.83M
Shares Outstanding80.81M
P/E Ratio (TTM)44.65
Price to Sales (P/S)3.89
Price to Book (P/B)4.55
EV/EBITDA26.53
Revenue (TTM)61.84M
Net Income (TTM)5.39M
Free Cash Flow (TTM)-11.69M
EPS (TTM)$0.07
Profit Margin8.72%
Operating Margin10.30%
Return on Equity (ROE)10.20%
Debt to Equity0.15
50-Day MA$2.11
200-Day MA$1.89
52-Week Change10.78%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Day's Range$2.95 - $3.02
52-Week High$3.10
52-Week Low$1.32
Open$2.98
Volume1.01M
Average Volume (3M)1.01M
Market Cap240.83M
Shares Outstanding80.81M
P/E Ratio (TTM)44.65
Price to Sales (P/S)3.89
Price to Book (P/B)4.55
EV/EBITDA26.53
Revenue (TTM)61.84M
Net Income (TTM)5.39M
Free Cash Flow (TTM)-11.69M
EPS (TTM)$0.07
Profit Margin8.72%
Operating Margin10.30%
Return on Equity (ROE)10.20%
Debt to Equity0.15
50-Day MA$2.11
200-Day MA$1.89
52-Week Change10.78%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Latest News
Recent news and articles about PLX